Vaniqa Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Discontinue use if hypersensitivity occurs.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


VANIQA (eflornithine hydrochloride) Cream, 13.9% is indicated for the reduction of unwanted facial hair in women.

VANIQA has only been studied on the face and adjacent involved areas under the chin of affected individuals. Usage should be limited to these areas of involvement.


There is currently no drug history available for this drug.

Other Information

VANIQA is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine hydrochloride as eflornithine hydrochloride monohydrate (150 mg/g).

Chemically, eflornithine hydrochloride is (±) -2-­(difluoromethyl) ornithine monohydrochloride monohydrate, with the empirical formula C 6H12F2N2O2• HCl•H2O, a molecular weight of 236.65 and the following structural formula:

Eflornithine Hydrochloried Chemical Structure

Anhydrous eflornithine hydrochloride has an empirical formula C6H12F 2N2O2• HCl and a molecular weight of 218.65.

Other ingredients include: ceteareth-20, cetearyl alcohol, dimethicone, glyceryl stearate, methylparaben, mineral oil, PEG-100 stearate, phenoxyethanol, propylparaben, stearyl alcohol and water.

Vaniqa Manufacturers

  • Physicians Total Care, Inc.
    Vaniqa (Eflornithine Hydrochloride) Cream [Physicians Total Care, Inc.]
  • Allergan, Inc.
    Vaniqa (Eflornithine Hydrochloride) Cream [Allergan, Inc.]

Login To Your Free Account